Cencora elects Frank Clyburn to its board of directors, effective Oct 1, 2024

Cencora, Inc.

Frank Clyburn appointed as independent director, effective October 1, 2024.
Board will increase from 11 to 13 members as a result.
Clyburn previously CEO of IFF and EVP at Merck; brings pharmaceutical industry expertise.
Compensation follows non-employee director policy, pro-rated until 2025 annual meeting.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Frank Clyburn

Director

COR · Cencora, Inc.

Effective: 2024-10-01
Filed: August 15, 2024, 7:59 PM ET

On August 13, 2024, the Board of Directors (the "Board") of Cencora, Inc. (the "Company") appointed Frank Clyburn to serve on the Board (the "Appointment"), with such Appointment to be effective as of October 1, 2024 (the "Effective Date").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Frank Clyburn was appointed as Director at Cencora, Inc..

Action: appointed
Role: Director

Exact text from the filing

On August 13, 2024, the Board of Directors (the "Board") of Cencora, Inc. (the "Company") appointed Frank Clyburn to serve on the Board (the "Appointment"), with such Appointment to be effective as of October 1, 2024 (the "Effective Date").

View on SEC.gov

Cencora, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-089929

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.